Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Change-Receivables" stands at -38.55 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value at least since 09/30/2012, the period currently displayed.
Kyowa Kirin Co Ltd's second quarter result of -22.26 Billion JPY for the item "Change Receivables" represents a decrease of -229.39 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of -22.26 Billion JPY for the item "Change Receivables" represents a decrease of -206.71 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of -38.55 Billion JPY for the item "Change Receivables" represents a decrease of -63.68 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -30.54 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -30.54 Billion Japanese Yens.
The 3 year change is -35.26 Billion Japanese Yens.
The 5 year change is -46.07 Billion Japanese Yens.
The 10 year change is -42.35 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change Receivables | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change Receivables | 486,508,953,600.00 |
![]() | AbbVie Inc - Change Receivables | 399,570,305,024.00 |
![]() | Roche Holding AG - Change Receivables | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change Receivables | 280,205,508,085.11 |